Annual Net Margin
-23.12 K%
+2599.68%+10.11%
December 31, 2022
Summary
- As of February 8, 2025, NAVB annual net profit margin is -23.12 thousand%, with the most recent change of +2599.68% (+10.11%) on December 31, 2022.
- During the last 3 years, NAVB annual net margin has risen by +18.01 thousand% (+43.79%).
- NAVB annual net margin is now -122092.51% below its all-time high of 18.95%, reached on December 31, 2000.
Performance
NAVB Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
N/A
September 30, 2023
Summary
- NAVB quarterly net profit margin is not available.
Performance
NAVB Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
NAVB Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.1% | - |
| 3 y3 years | +43.8% | - |
| 5 y5 years | - | - |
NAVB Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +10.1% | ||
| 5 y | 5-year | -156.0% | +43.8% | ||
| alltime | all time | <-9999.0% | +43.8% |
Navidea Biopharmaceuticals Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -23.12 K%(-10.1%) | -570.92 K%(+651.8%) |
| Sep 2022 | - | -75.94 K%(+65.1%) |
| Jun 2022 | - | -46.01 K%(-88.0%) |
| Dec 2021 | -25.72 K%(+184.8%) | -384.44 K%(+1337.6%) |
| Sep 2021 | - | -26.74 K%(+30.6%) |
| Jun 2021 | - | -20.47 K%(+55.1%) |
| Mar 2021 | - | -13.19 K%(+310.4%) |
| Dec 2020 | -9030.69%(-78.0%) | -3215.00%(-92.5%) |
| Sep 2020 | - | -42.81 K%(+64.2%) |
| Jun 2020 | - | -26.07 K%(+48.4%) |
| Mar 2020 | - | -17.57 K%(-83.0%) |
| Dec 2019 | -41.13 K%(+723.2%) | -103.43 K%(+64.7%) |
| Sep 2019 | - | -62.80 K%(+273.4%) |
| Jun 2019 | - | -16.82 K%(-78.2%) |
| Mar 2019 | - | -77.11 K%(+755.0%) |
| Dec 2018 | -4996.24%(+1636.0%) | -9019.24%(-47.3%) |
| Sep 2018 | - | -17.13 K%(+1791.4%) |
| Jun 2018 | - | -905.55%(-99.9%) |
| Mar 2018 | - | -847.54 K%(+1806.0%) |
| Dec 2017 | - | -44.47 K%(+757.2%) |
| Jun 2017 | - | -5187.56%(>+9900.0%) |
| Dec 2016 | -287.80%(-68.5%) | - |
| Sep 2016 | - | -3.26%(-99.4%) |
| Jun 2016 | - | -572.43%(+47.3%) |
| Mar 2016 | - | -388.62%(-1308.0%) |
| Dec 2015 | -914.68%(+60.7%) | 32.17%(-115.9%) |
| Sep 2015 | - | -202.82%(-40.0%) |
| Jun 2015 | - | -337.92%(-2.3%) |
| Mar 2015 | - | -345.80%(+10.7%) |
| Dec 2014 | -569.36%(-84.9%) | -312.29%(+1.9%) |
| Sep 2014 | - | -306.61%(-67.8%) |
| Jun 2014 | - | -951.18%(-39.1%) |
| Mar 2014 | - | -1561.65%(-39.2%) |
| Dec 2013 | -3776.61%(-89.8%) | -2570.55%(-9.0%) |
| Sep 2013 | - | -2823.91%(-46.5%) |
| Jun 2013 | - | -5274.74%(-95.0%) |
| Dec 2012 | -37.03 K%(+357.6%) | -106.28 K%(+992.9%) |
| Jun 2012 | - | -9724.70%(-83.4%) |
| Mar 2012 | - | -58.58 K%(+64.2%) |
| Jun 2011 | - | -35.68 K%(+2610.6%) |
| Mar 2011 | - | -1316.26%(+199.9%) |
| Dec 2010 | -8092.89%(+1844.9%) | -438.91%(-72.4%) |
| Sep 2010 | - | -1592.15%(-6.1%) |
| Jun 2010 | - | -1696.41%(+1750.0%) |
| Mar 2010 | - | -91.70%(+663.5%) |
| Dec 2009 | -416.11%(+511.3%) | -12.01%(-98.8%) |
| Sep 2009 | - | -966.70%(+15.4%) |
| Jun 2009 | - | -837.97%(-2861.0%) |
| Mar 2009 | - | 30.35%(-143.2%) |
| Dec 2008 | -68.07%(-4.7%) | -70.27%(-33.1%) |
| Sep 2008 | - | -105.02%(+132.4%) |
| Jun 2008 | - | -45.18%(-21.5%) |
| Mar 2008 | - | -57.55%(-43.1%) |
| Dec 2007 | -71.42%(-8.8%) | -101.16%(+113.2%) |
| Sep 2007 | - | -47.44%(-36.6%) |
| Jun 2007 | - | -74.77%(+17.3%) |
| Mar 2007 | - | -63.72%(-8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | -78.35%(-5.9%) | -69.25%(-60.0%) |
| Sep 2006 | - | -172.91%(+187.8%) |
| Jun 2006 | - | -60.07%(+15.8%) |
| Mar 2006 | - | -51.88%(-43.2%) |
| Dec 2005 | -83.27%(+40.0%) | -91.41%(-5.1%) |
| Sep 2005 | - | -96.32%(+21.9%) |
| Jun 2005 | - | -79.04%(+15.5%) |
| Mar 2005 | - | -68.41%(-62.4%) |
| Dec 2004 | -59.49%(+115.3%) | -182.13%(+1216.0%) |
| Sep 2004 | - | -13.84%(-50.2%) |
| Jun 2004 | - | -27.77%(-32.7%) |
| Mar 2004 | - | -41.29%(+34.5%) |
| Dec 2003 | -27.63%(-54.1%) | -30.70%(-44.8%) |
| Sep 2003 | - | -55.60%(+1223.8%) |
| Jun 2003 | - | -4.20%(-86.5%) |
| Mar 2003 | - | -31.10%(+216.4%) |
| Dec 2002 | -60.23%(<-9900.0%) | -9.83%(-91.6%) |
| Sep 2002 | - | -117.72%(+71.0%) |
| Jun 2002 | - | -68.85%(-13.6%) |
| Mar 2002 | - | -79.71%(+162.5%) |
| Dec 2001 | 0.18%(-99.1%) | -30.36%(-245.2%) |
| Sep 2001 | - | 20.91%(+168.4%) |
| Jun 2001 | - | 7.79%(+55.5%) |
| Mar 2001 | - | 5.01%(-80.5%) |
| Dec 2000 | 18.95%(-142.9%) | 25.67%(+18.4%) |
| Sep 2000 | - | 21.68%(-8.1%) |
| Jun 2000 | - | 23.58%(-1726.2%) |
| Mar 2000 | - | -1.45%(-98.0%) |
| Dec 1999 | -44.19%(-90.8%) | - |
| Jun 1999 | - | -73.68%(+7.7%) |
| Mar 1999 | - | -68.42%(-86.1%) |
| Dec 1998 | -480.61%(+6.0%) | -493.57%(+49.8%) |
| Sep 1998 | - | -329.41%(-19.2%) |
| Jun 1998 | - | -407.69%(-48.3%) |
| Mar 1998 | - | -788.89%(+119.7%) |
| Dec 1997 | -453.33%(-74.1%) | -359.14%(-13.5%) |
| Sep 1997 | - | -415.38%(-36.5%) |
| Jun 1997 | - | -654.55%(+53.2%) |
| Mar 1997 | - | -427.27%(-70.9%) |
| Dec 1996 | -1750.00%(+62.0%) | -1466.67%(-30.2%) |
| Sep 1996 | - | -2100.00%(-4.5%) |
| Jun 1996 | - | -2200.00%(+22.2%) |
| Mar 1996 | - | -1800.00%(+63.6%) |
| Dec 1995 | -1080.00%(-10.0%) | -1100.00%(-56.0%) |
| Sep 1995 | - | -2500.00%(+200.0%) |
| Jun 1995 | - | -833.33%(0.0%) |
| Mar 1995 | - | -833.33%(+19.0%) |
| Dec 1994 | -1200.00%(-85.0%) | -700.00%(-57.6%) |
| Sep 1994 | - | -1650.00%(+65.0%) |
| Jun 1994 | - | -1000.00%(-61.5%) |
| Mar 1994 | - | -2600.00%(+18.2%) |
| Dec 1993 | -8000.00%(+207.7%) | - |
| Sep 1993 | - | -2200.00%(+10.0%) |
| Jun 1993 | - | -2000.00%(+53.8%) |
| Mar 1993 | - | -1300.00%(+44.4%) |
| Dec 1992 | -2600.00% | - |
| Sep 1992 | - | -900.00% |
FAQ
- What is Navidea Biopharmaceuticals annual net profit margin?
- What is the all time high annual net margin for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals annual net margin year-on-year change?
- What is the all time high quarterly net margin for Navidea Biopharmaceuticals?
What is Navidea Biopharmaceuticals annual net profit margin?
The current annual net margin of NAVB is -23.12 K%
What is the all time high annual net margin for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual net profit margin is 18.95%
What is Navidea Biopharmaceuticals annual net margin year-on-year change?
Over the past year, NAVB annual net profit margin has changed by +2599.68% (+10.11%)
What is the all time high quarterly net margin for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly net profit margin is 32.17%